EVO - Why Germany-Based Life Science Company Evotec Shares Are Falling Today | Benzinga
Evotec SE (NASDAQ: EVO) shares are trading lower on Thursday in the premarket session.
Yesterday, the company said CEO Werner Lanthaler stepped down as CEO. Lanthaler will not continue to serve until the end of his current term, for personal reasons.
The company, however, confirmed guidance for 2023. On Nov. 8, the company said revenues expected to be in the range of €750 million-€790 million in 2023, or Full story available on Benzinga.com